Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-19-045647)

Filing Details

Accession Number:: 0001209191-19-045647
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-08-12 19:47:03
Reporting Period:: 2019-08-09

Accepted Time:: 2019-08-12 19:47:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1645666	Kezar Life Sciences Inc.	KZR	Pharmaceutical Preparations (2834)	473366145

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1744263	Franklin John Fowler	C/O Kezar Life Sciences, Inc. 4000 Shoreline Court, Suite 300 South San Francisco CA 94080	Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-08-09	500	$5.26	293,204	No	4	P	Direct
Common Stock	Acquisiton	2019-08-09	750	$5.01	293,954	No	4	P	Indirect	By Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	By Trust

Footnotes

The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $4.9642 to $5.1143 on August 9, 2019. The reporting person will provide upon request to the SEC, the issuer or security holder of issuer, full information regarding the number of shares purchased at each separate price.